# SteadiSet™ Pilot Study (SteP Study)

> **NCT04591925** · NA · TERMINATED · sponsor: **Capillary Biomedical, Inc.** · enrollment: 13 (actual)

## Conditions studied

- Diabetes Mellitus, Type I
- IDDM
- Diabetes Mellitus, Insulin-Dependent, 1
- Type 1 Diabetes
- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Control Device insulin infusion devcie
- **DEVICE:** Investigative insulin infusion devcie

## Key facts

- **NCT ID:** NCT04591925
- **Lead sponsor:** Capillary Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-05
- **Primary completion:** 2021-11-02
- **Final completion:** 2021-11-02
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Interim analysis
- **Last updated:** 2022-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591925, "SteadiSet™ Pilot Study (SteP Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04591925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*